Estudios

Neurología

Abdolahi M, Tafakhori A, Togha M et al. The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients. Immunogenetics. 2017 Jun;69(6):371-378. Español Abdolahi M, Tafakhori A, Togha M et al. The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients. Immunogenetics. 2017 Jun;69(6):371-378. https://www.ncbi.nlm.nih.gov/pubmed/28478481 Neurología No 07/20/2017 4108 McNamara RK, Asch RH, Lindquist DM et al. Role of polyunsaturated fatty acids in human brain structure and function across the lifespan: An update on neuroimaging findings. Prostaglandins Leukot Essent Fatty Acids. 2017 May 9. Español McNamara RK, Asch RH, Lindquist DM et al. Role of polyunsaturated fatty acids in human brain structure and function across the lifespan: An update on neuroimaging findings. Prostaglandins Leukot Essent Fatty Acids. 2017 May 9. http://www.plefa.com/article/S0952-3278(16)30219-8/fulltext Neurología No 06/01/2017 4119 Dong Y, Xu M, Kalueff AV et al. Dietary eicosapentaenoic acid normalizes hippocampal omega-3 and 6 polyunsaturated fatty acid profile, attenuates glial activation and regulates BDNF function in a rodent model of neuroinflammation induced by central interl Español Dong Y, Xu M, Kalueff AV et al. Dietary eicosapentaenoic acid normalizes hippocampal omega-3 and 6 polyunsaturated fatty acid profile, attenuates glial activation and regulates BDNF function in a rodent model of neuroinflammation induced by central interleukin-1β administration. Eur J Nutr. 2017 May 18. https://link.springer.com/article/10.1007%2Fs00394-017-1462-7 Neurología No 05/25/2017 4120 Andreone BJ, Wai Chow B, Tata A, Lacoste B, Ben-Zvi A, Bullock K, Deik AA, Ginty DD, Clish CB, Gu C. Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis. Neuron. 2017 May 3;94(3):581-594 Español Andreone BJ, Wai Chow B, Tata A, Lacoste B, Ben-Zvi A, Bullock K, Deik AA, Ginty DD, Clish CB, Gu C. Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis. Neuron. 2017 May 3;94(3):581-594.e5. doi: 10.1016/j.neuron.2017.03.043. Epub 2017 Apr 13. https://www.ncbi.nlm.nih.gov/pubmed/28416077 Neurología No 05/03/2017 3979 Siegert E, Paul F, Rothe M, Weylandt KH. The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice. BMC Neurosci. 2017 Jan 24;18(1):19. Español Siegert E, Paul F, Rothe M, Weylandt KH. The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice. BMC Neurosci. 2017 Jan 24;18(1):19. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259863/ Neurología Full text 01/24/2017 3911 Liu ZH, Yip PK, Priestley JV, Michael-Titus AT. A Single Dose of Docosahexaenoic Acid Increases the Functional Recovery Promoted by Rehabilitation after Cervical Spinal Cord Injury in the Rat. J Neurotrauma. 2017 Jan 13. Español Liu ZH, Yip PK, Priestley JV, Michael-Titus AT. A Single Dose of Docosahexaenoic Acid Increases the Functional Recovery Promoted by Rehabilitation after Cervical Spinal Cord Injury in the Rat. J Neurotrauma. 2017 Jan 13. https://www.ncbi.nlm.nih.gov/pubmed/27881040 Neurología No 01/13/2017 3912

Autismo

Parellada M, Llorente C, Calvo R, et al. Randomized trial of omega-3 for autism spectrum disorders: Effect on cell membrane composition and behavior. Eur Neuropsychopharmacol. 2017 Sep 18. Español Parellada M, Llorente C, Calvo R, et al. Randomized trial of omega-3 for autism spectrum disorders: Effect on cell membrane composition and behavior. Eur Neuropsychopharmacol. 2017 Sep 18. https://www.ncbi.nlm.nih.gov/pubmed/28935269 Autismo No 2017-09-18 00:00:00 4405 Brigandi SA, Shao H, Qian SY et al. Autistic children exhibit decreased levels of essential Fatty acids in red blood cells. Int J Mol Sci. 2015 May 4;16(5):10061-76. doi: 10.3390/ijms160510061. Español Brigandi SA, Shao H, Qian SY et al. Autistic children exhibit decreased levels of essential Fatty acids in red blood cells. Int J Mol Sci. 2015 May 4;16(5):10061-76. doi: 10.3390/ijms160510061. http://www.mdpi.com/1422-0067/16/5/10061/htm Autismo Full text 2015-05-04 00:00:00 2531 Brigandi SA, Shao H, Qian SY, Shen Y, Wu BL, Kang JX. Autistic children exhibit decreased levels of essential Fatty acids in red blood cells. Int J Mol Sci. 2015 May 4;16(5):10061-76. doi: 10.3390/ijms160510061. Español Brigandi SA, Shao H, Qian SY, Shen Y, Wu BL, Kang JX. Autistic children exhibit decreased levels of essential Fatty acids in red blood cells. Int J Mol Sci. 2015 May 4;16(5):10061-76. doi: 10.3390/ijms160510061. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463632/ Autismo Full text 2015-05-04 00:00:00 2535 Yan CL, Zhang J, Hou Y. Decreased plasma levels of lipoxin A4 in children with autism spectrum disorders. Neuroreport. 2015 Apr 15;26(6):341-5. doi: 10.1097/WNR. Español Yan CL, Zhang J, Hou Y. Decreased plasma levels of lipoxin A4 in children with autism spectrum disorders. Neuroreport. 2015 Apr 15;26(6):341-5. doi: 10.1097/WNR. http://www.ncbi.nlm.nih.gov/pubmed/25714424 Autismo No 2015-04-15 00:00:00 2539 Ooi YP, Weng SJ, Jang LY, Low L, Seah J, Teo S, Ang RP, Lim CG, Liew A, Fung DS, Sung M. Omega-3 fatty acids in the management of autism spectrum disorders: findings from an open-label pilot study in Singapore. Eur J Clin Nutr. 2015 Mar 25. doi: 10.1038/e Español Ooi YP, Weng SJ, Jang LY, Low L, Seah J, Teo S, Ang RP, Lim CG, Liew A, Fung DS, Sung M. Omega-3 fatty acids in the management of autism spectrum disorders: findings from an open-label pilot study in Singapore. Eur J Clin Nutr. 2015 Mar 25. doi: 10.1038/ejcn.2015.28. http://www.ncbi.nlm.nih.gov/pubmed/25804268 Autismo No 2015-03-25 00:00:00 2536 Al-Farsi YM, Waly MI, Deth RC et al. Impact of nutrition on serum levels of docosahexaenoic acid among Omani children with autism. Nutrition. 2013;29(9):1142-1146. Español Al-Farsi YM, Waly MI, Deth RC et al. Impact of nutrition on serum levels of docosahexaenoic acid among Omani children with autism. Nutrition. 2013;29(9):1142-1146. http://www.ncbi.nlm.nih.gov/pubmed/23800562 Autismo No 2013-01-01 00:00:00 2526 Bent S, Bertoglio K, Ashwood P et al. A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J Autism Dev Disord. 2011 May;41(5):545-54. Español Bent S, Bertoglio K, Ashwood P et al. A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J Autism Dev Disord. 2011 May;41(5):545-54. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076562/pdf/10803_2010_Article_1078.pdf Autismo Full text 2011-05-02 00:00:00 2528

Demencia y Alzheimer

Shang J, Yamashita T, Fukui Y, Song D, Li X, Zhai Y, et al. Different Associations of Plasma Biomarkers in Alzheimer's Disease, Mild Cognitive Impairment, Vascular Dementia, and Ischemic Stroke. J Clin Neurol. 2018;14(1):29-34. Español Shang J, Yamashita T, Fukui Y, Song D, Li X, Zhai Y, et al. Different Associations of Plasma Biomarkers in Alzheimer's Disease, Mild Cognitive Impairment, Vascular Dementia, and Ischemic Stroke. J Clin Neurol. 2018;14(1):29-34. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765253/ Demencia y Alzheimer No 2018-10-21 00:00:00 4965 van Lent DM, Weinhold L, Wolfsgruber S, Schmid M, Maier W, Jessen F, et al. Eicosapentanoic acid but not docosahexaenoic acid is associated with Alzheimer's disease risk in the oldest old. Presented at: 2018 Alzheimer's Association International Conferenc Español van Lent DM, Weinhold L, Wolfsgruber S, Schmid M, Maier W, Jessen F, et al. Eicosapentanoic acid but not docosahexaenoic acid is associated with Alzheimer's disease risk in the oldest old. Presented at: 2018 Alzheimer's Association International Conference. July 22-26, 2018; Chicago, IL. Abstract 22855 https://ep70.eventpilotadmin.com/web/planner.php?id=AAIC18 Demencia y Alzheimer No 2018-10-21 00:00:00 5049 Derbyshire E. Brain health across the lifespan: a systematic review on the role of omega-3 fatty acid supplements. Nutrients. 2018 Aug 15;10(8). Español Derbyshire E. Brain health across the lifespan: a systematic review on the role of omega-3 fatty acid supplements. Nutrients. 2018 Aug 15;10(8). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116096/ Demencia y Alzheimer No 2018-10-21 00:00:00 5050 Zhu M, Wang X, Hjorth E, et al. Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis. Mol Neurobiol. 2016;53(4):2733-49. Español Zhu M, Wang X, Hjorth E, et al. Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis. Mol Neurobiol. 2016;53(4):2733-49. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824659/ Demencia y Alzheimer No 2018-10-01 00:00:00 4900 Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review Robert A. Whittington, Emmanuel Planel and Niccolò Terrando Español Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review Robert A. Whittington, Emmanuel Planel and Niccolò Terrando https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681480/ Demencia y Alzheimer No 2017-11-06 00:00:00 4430 Ammann EM, Pottala JV, Robinson JG, Espeland MA, Harris WS. Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS). Prostaglandins Le Español Ammann EM, Pottala JV, Robinson JG, Espeland MA, Harris WS. Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS). Prostaglandins Leukot Essent Fatty Acids. 2017;121:68-75. https://www.ncbi.nlm.nih.gov/pubmed/28651700 Demencia y Alzheimer No 2017-06-21 00:00:00 4332 Nock TG, Chouinard-Watkins R, Plourde M. Carriers of an apolipoprotein E epsilon 4 allele are more vulnerable to a dietary deficiency in omega-3 fatty acids and cognitive decline. Biochim Biophys Acta. 2017 Jul 18;1862(10 Pt A):1068-1078. Español Nock TG, Chouinard-Watkins R, Plourde M. Carriers of an apolipoprotein E epsilon 4 allele are more vulnerable to a dietary deficiency in omega-3 fatty acids and cognitive decline. Biochim Biophys Acta. 2017 Jul 18;1862(10 Pt A):1068-1078. https://www.ncbi.nlm.nih.gov/pubmed/28733268 Demencia y Alzheimer No 2017-06-15 00:00:00 4335 Grimm MO, Michaelson D, Hartmann T. Omega-3 fatty acids, lipids and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention. J Lipid Res. 2017 May 20. Español Grimm MO, Michaelson D, Hartmann T. Omega-3 fatty acids, lipids and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention. J Lipid Res. 2017 May 20. http://www.jlr.org/content/early/2017/05/20/jlr.R076331.full.pdf Demencia y Alzheimer Full text 2017-05-31 00:00:00 4157 Fiala M, Kooij G, Wagner K et al. Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids. FASEB J. 2017 Apr 18. Español Fiala M, Kooij G, Wagner K et al. Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids. FASEB J. 2017 Apr 18. https://www.ncbi.nlm.nih.gov/pubmed/28420693 Demencia y Alzheimer No 2017-05-01 00:00:00 4154 Yassine HN, Braskie MN, Mack WJ, Castor KJ, Fonteh AN, Schneider LS, Harrington MG, Chui HC. Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review. JAMA Neurol. 2017 Mar 1;74(3):339-347. Español Yassine HN, Braskie MN, Mack WJ, Castor KJ, Fonteh AN, Schneider LS, Harrington MG, Chui HC. Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review. JAMA Neurol. 2017 Mar 1;74(3):339-347. https://www.ncbi.nlm.nih.gov/pubmed/28114437 Demencia y Alzheimer No 2017-03-01 00:00:00 3946 Ren H, Luo C, Feng Y Yao X, Shi Z, Liang F, Kang JX, Wan JB, Pei Z, Su H. Omega-3 polyunsaturated fatty acids promote amyloid-β clearance from the brain through mediating the function of the glymphatic system. FASEB J. 2017 Jan;31(1):282-293. Español Ren H, Luo C, Feng Y Yao X, Shi Z, Liang F, Kang JX, Wan JB, Pei Z, Su H. Omega-3 polyunsaturated fatty acids promote amyloid-β clearance from the brain through mediating the function of the glymphatic system. FASEB J. 2017 Jan;31(1):282-293. https://www.ncbi.nlm.nih.gov/pubmed/27789520 Demencia y Alzheimer No 2017-01-01 00:00:00 3951 Yanai H. Effects of N-3 Polyunsaturated Fatty Acids on Dementia. J Clin Med Res. 2017 Jan;9(1):1-9. Español Yanai H. Effects of N-3 Polyunsaturated Fatty Acids on Dementia. J Clin Med Res. 2017 Jan;9(1):1-9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127208/ Demencia y Alzheimer Full text 2017-01-01 00:00:00 3955 Grimm MO, Mett J, Stahlmann CP, Haupenthal VJ, Blümel T, Stötzel H, Grimm HS, Hartmann T. Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme. Biochem Cell Biol. 2016 Dec;94(6):534-542 Español Grimm MO, Mett J, Stahlmann CP, Haupenthal VJ, Blümel T, Stötzel H, Grimm HS, Hartmann T. Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme. Biochem Cell Biol. 2016 Dec;94(6):534-542. https://www.ncbi.nlm.nih.gov/pubmed/27813426 Demencia y Alzheimer No 2016-12-01 00:00:00 3952 Belkouch M, Hachem M, Elgot A, Lo Van A, Picq M, Guichardant M, Lagarde M, Bernoud-Hubac N. The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease. J Nutr Biochem. 2016 Dec;38:1-11. Español Belkouch M, Hachem M, Elgot A, Lo Van A, Picq M, Guichardant M, Lagarde M, Bernoud-Hubac N. The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease. J Nutr Biochem. 2016 Dec;38:1-11. https://www.ncbi.nlm.nih.gov/pubmed/27825512 Demencia y Alzheimer No 2016-12-01 00:00:00 3948 Eriksdotter M, Vedin I, Falahati F, Freund-Levi Y, Hjorth E, Faxen-Irving G, Wahlund LO, Schultzberg M, Basun H, Cederholm T, Palmblad J. Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fa Español Eriksdotter M, Vedin I, Falahati F, Freund-Levi Y, Hjorth E, Faxen-Irving G, Wahlund LO, Schultzberg M, Basun H, Cederholm T, Palmblad J. Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study. J Alzheimers Dis. 2015 Oct 1;48(3):805-12. http://www.ncbi.nlm.nih.gov/pubmed/26402079 Demencia y Alzheimer No 2015-10-01 00:00:00 3105 Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J. 2015 Jul;29(7):2681-9. Español Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J. 2015 Jul;29(7):2681-9. http://www.ncbi.nlm.nih.gov/pubmed/25805829 Demencia y Alzheimer No 2015-07-01 00:00:00 2568 Casali BT, Corona AW, Mariani MM, Karlo JC, Ghosal K, Landreth GE. Omega-3 Fatty Acids Augment the Actions of Nuclear Receptor Agonists in a Mouse Model of Alzheimer's Disease. J Neurosci. 2015 Jun 17;35(24):9173-81. Español Casali BT, Corona AW, Mariani MM, Karlo JC, Ghosal K, Landreth GE. Omega-3 Fatty Acids Augment the Actions of Nuclear Receptor Agonists in a Mouse Model of Alzheimer's Disease. J Neurosci. 2015 Jun 17;35(24):9173-81. http://www.ncbi.nlm.nih.gov/pubmed/26085639 Demencia y Alzheimer No 2015-06-17 00:00:00 2564 Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J. 2015 Mar 24. pii: fj.14-264218. Español Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J. 2015 Mar 24. pii: fj.14-264218. http://www.ncbi.nlm.nih.gov/pubmed/25805829 Demencia y Alzheimer No 2015-03-24 00:00:00 2641 Shinto L, Quinn J, Montine T, Dodge HH, Woodward W, Baldauf-Wagner S, Waichunas D, Bumgarner L, Bourdette D, Silbert L, Kaye J. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease. J Alzheimers D Español Shinto L, Quinn J, Montine T, Dodge HH, Woodward W, Baldauf-Wagner S, Waichunas D, Bumgarner L, Bourdette D, Silbert L, Kaye J. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease. J Alzheimers Dis. 2014;38(1):111-20. doi: 10.3233/JAD-130722. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886557/ Demencia y Alzheimer Full text 2014-01-01 00:00:00 2652 Wiesmann M, Kiliaan AJ, Claassen JA. Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab. 2013 Nov;33(11):1696-706. Español Wiesmann M, Kiliaan AJ, Claassen JA. Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab. 2013 Nov;33(11):1696-706. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824191/ Demencia y Alzheimer Full text 2013-11-01 00:00:00 2655 Zhao Y, Calon F, Julien C et al. Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPAR?-mediated mechanisms in Alzheimer's disease models. PLoS One. 2011 Jan 5;6(1):e15816. Español Zhao Y, Calon F, Julien C et al. Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPAR?-mediated mechanisms in Alzheimer's disease models. PLoS One. 2011 Jan 5;6(1):e15816. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016440/pdf/pone.0015816.pdf Demencia y Alzheimer Full text 2011-01-05 00:00:00 2658 Caballer García J. Los ácidos grasos omega-3 en la prevención de la enfermedad de Alzheimer. Alzheimer. Real Invest Demenc. 2011;49:12-18. Español Caballer García J. Los ácidos grasos omega-3 en la prevención de la enfermedad de Alzheimer. Alzheimer. Real Invest Demenc. 2011;49:12-18. http://revistaalzheimer.com/PDF/0239.pdf Demencia y Alzheimer Full text 2011-01-01 00:00:00 2636 Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr, Weiner M, Shinto L, Aisen PS. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010 Nov 3;304(17) Español Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr, Weiner M, Shinto L, Aisen PS. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010 Nov 3;304(17):1903-11. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259852/ Demencia y Alzheimer Full text 2010-11-03 00:00:00 2651 Jicha GA, Markesbery WR. Omega-3 fatty acids: potential role in the management of early Alzheimer's disease. Clin Interv Aging. 2010 Apr 7;5:45-61. Español Jicha GA, Markesbery WR. Omega-3 fatty acids: potential role in the management of early Alzheimer's disease. Clin Interv Aging. 2010 Apr 7;5:45-61. https://www.dovepress.com/getfile.php?fileID=5956 Demencia y Alzheimer Full text 2010-04-07 00:00:00 2647 Fotuhi M, Mohassel P, Yaffe K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol. 2009 Mar;5(3):140-52. Español Fotuhi M, Mohassel P, Yaffe K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol. 2009 Mar;5(3):140-52. http://www.ncbi.nlm.nih.gov/pubmed/19262590 Demencia y Alzheimer No 2009-03-05 00:00:00 2642 Palmblad J, Eriksdotter-Jönhagen M, Freund-Levi Y, Cederholm T. Omega-3-fatty acids protect against dementia. Also early symptoms of mild Alzheimer disease seem to be inhibited. Lakartidningen. 2007 Oct 31-Nov 6;104(44):3268-71. Español Palmblad J, Eriksdotter-Jönhagen M, Freund-Levi Y, Cederholm T. Omega-3-fatty acids protect against dementia. Also early symptoms of mild Alzheimer disease seem to be inhibited. Lakartidningen. 2007 Oct 31-Nov 6;104(44):3268-71. http://www.ncbi.nlm.nih.gov/pubmed/18050989 Demencia y Alzheimer No 2007-10-31 00:00:00 2648

Deterioro cognitivo

McNamara RK, Kalt W, Shidler MD, McDonald J, Summer SS, Stein AL, et al. Cognitive response to fish oil, blueberry, and combined supplementation in older adults with subjective cognitive impairment. Neurobiol Aging. 2018;64:147-56. Español McNamara RK, Kalt W, Shidler MD, McDonald J, Summer SS, Stein AL, et al. Cognitive response to fish oil, blueberry, and combined supplementation in older adults with subjective cognitive impairment. Neurobiol Aging. 2018;64:147-56. https://www.sciencedirect.com/science/article/pii/S0197458017303974 Deterioro cognitivo No 2018-10-21 00:00:00 5021 Stilling F, Wolk A, Religa D, Leppert J, Bergkvist L, Michaëlsson K, et al. Adipose tissue fatty acid composition and cognitive impairment. Nutrition. 2018;54:153-7. Español Stilling F, Wolk A, Religa D, Leppert J, Bergkvist L, Michaëlsson K, et al. Adipose tissue fatty acid composition and cognitive impairment. Nutrition. 2018;54:153-7. https://www.ncbi.nlm.nih.gov/pubmed/29982142 Deterioro cognitivo No 2018-10-21 00:00:00 5051 Pérez-Gálvez A, Jarén-Galán M, Garrido-Fernández J, Calvo MV, Visioli F, Fontecha J. Activities, bioavailability, and metabolism of lipids from structural membranes and oils: Promising research on mild cognitive impairment. Pharmacol Res. 2018 Jul 20;134: Español Pérez-Gálvez A, Jarén-Galán M, Garrido-Fernández J, Calvo MV, Visioli F, Fontecha J. Activities, bioavailability, and metabolism of lipids from structural membranes and oils: Promising research on mild cognitive impairment. Pharmacol Res. 2018 Jul 20;134:299-304. https://www.ncbi.nlm.nih.gov/pubmed/30016644 Deterioro cognitivo No 2018-10-21 00:00:00 5052 Famenini S, Rigali EA, Olivera-Perez HM, Dang J, Chang MT, Halder R, Rao RV, Pellegrini M, Porter V, Bredesen D, Fiala M. Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementat Español Famenini S, Rigali EA, Olivera-Perez HM, Dang J, Chang MT, Halder R, Rao RV, Pellegrini M, Porter V, Bredesen D, Fiala M. Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementation. FASEB J. 2017 Jan;31(1):148-160. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161513/ Deterioro cognitivo Full text 2017-01-01 00:00:00 3945 Cutuli D. Functional and structural benefits induced by omega-3 polyunsaturated fatty acids during aging. Curr Neuropharmacol. 2016 Jun 13. [Epub ahead of print] Español Cutuli D. Functional and structural benefits induced by omega-3 polyunsaturated fatty acids during aging. Curr Neuropharmacol. 2016 Jun 13. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27306037 Deterioro cognitivo No 2016-06-13 00:00:00 3484 Hashimoto M, Kato S, Tanabe Y et al. Beneficial effects of dietary docosahexaenoic acid intervention on cognitive function and mental health of the oldest elderly in Japanese care facilities and nursing homes. Geriatr Gerontol Int. 2016 Jan 28. doi: 10.11 Español Hashimoto M, Kato S, Tanabe Y et al. Beneficial effects of dietary docosahexaenoic acid intervention on cognitive function and mental health of the oldest elderly in Japanese care facilities and nursing homes. Geriatr Gerontol Int. 2016 Jan 28. doi: 10.1111/ggi.12691. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26822516 Deterioro cognitivo No 2016-01-28 00:00:00 3485 Oulhaj A, Jernerén F, Refsum H et al. Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment. J Alzheimers Dis. 2016 Jan 6. [Epub ahead of print] Español Oulhaj A, Jernerén F, Refsum H et al. Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment. J Alzheimers Dis. 2016 Jan 6. [Epub ahead of print] http://content.iospress.com/articles/journal-of-alzheimers-disease/jad150777 Deterioro cognitivo Full text 2016-01-06 00:00:00 3488 Köbe T, Witte AV, Schnelle A, Lesemann A, Fabian S, Tesky VA, Pantel J, Flöel A. Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with Español Köbe T, Witte AV, Schnelle A, Lesemann A, Fabian S, Tesky VA, Pantel J, Flöel A. Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment. Neuroimage. 2015 Oct 1. pii: S1053-8119(15)00872-1. http://www.ncbi.nlm.nih.gov/pubmed/26433119 Deterioro cognitivo No 2015-10-01 00:00:00 3104 Rathod RS, Khaire AA, Kale AA, Joshi SR. “Beneficial effects of omega-3 fatty acids and vitamin B12 supplementation on brain docosahexaenoic acid, brain derived neurotrophic factor, and cognitive performance in the second-generation Wistar rats.” Abstract Español Rathod RS, Khaire AA, Kale AA, Joshi SR. Beneficial effects of omega-3 fatty acids and vitamin B12 supplementation on brain docosahexaenoic acid, brain derived neurotrophic factor, and cognitive performance in the second-generation Wistar rats. Biofactors. 2015 Jul-Aug;41(4):261-72. http://www.ncbi.nlm.nih.gov/pubmed/26249019 Deterioro cognitivo No 2015-07-01 00:00:00 2532 Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015 Jul;102(1):215-21. Español Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015 Jul;102(1):215-21. http://www.ncbi.nlm.nih.gov/pubmed/25877495 Deterioro cognitivo No 2015-07-01 00:00:00 3169 Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. “Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial.” Am J Clin Nutr. 2015 Jul;102(1):215-21. Español Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015 Jul;102(1):215-21. http://www.ncbi.nlm.nih.gov/pubmed/25877495 Deterioro cognitivo No 2015-07-01 00:00:00 2554 Lorente-Cebrián S, Costa AG, Navas-Carretero S, Zabala M, Laiglesia LM, Martínez JA, Moreno-Aliaga MJ. “An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases.” J Physiol Biochem. 2015 Jun;71(2):341-9. doi: 10.1007/s13105-0 Español Lorente-Cebrián S, Costa AG, Navas-Carretero S, Zabala M, Laiglesia LM, Martínez JA, Moreno-Aliaga MJ. An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases. J Physiol Biochem. 2015 Jun;71(2):341-9. doi: 10.1007/s13105-015-0395-y. http://www.ncbi.nlm.nih.gov/pubmed/25752887 Deterioro cognitivo No 2015-06-01 00:00:00 2558 Pusceddu MM, Kelly P, Ariffin N, Cryan JF, Clarke G, Dinan TG. n-3 PUFAs have beneficial effects on anxiety and cognition in female rats: Effects of early life stress. Psychoneuroendocrinology. 2015 Apr 28;58:79-90. doi: 10.1016/j.psyneuen.2015.04.015. Español Pusceddu MM, Kelly P, Ariffin N, Cryan JF, Clarke G, Dinan TG. n-3 PUFAs have beneficial effects on anxiety and cognition in female rats: Effects of early life stress. Psychoneuroendocrinology. 2015 Apr 28;58:79-90. doi: 10.1016/j.psyneuen.2015.04.015. http://www.ncbi.nlm.nih.gov/pubmed/25965872 Deterioro cognitivo No 2015-04-28 00:00:00 2625 Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015 Apr 15. pii: ajcn103 Español Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015 Apr 15. pii: ajcn103283. http://www.ncbi.nlm.nih.gov/pubmed/25877495 Deterioro cognitivo No 2015-04-15 00:00:00 2616 Dehkordi NG, Noorbakhshnia M, Ghaedi K, Esmaeili A, Dabaghi M. Omega-3 fatty acids prevent LPS-induced passive avoidance learning and memory and CaMKII-α gene expression impairments in hippocampus of rat. Pharmacol Rep. 2015 Apr;67(2):370-5. doi: 10.1016/ Español Dehkordi NG, Noorbakhshnia M, Ghaedi K, Esmaeili A, Dabaghi M. Omega-3 fatty acids prevent LPS-induced passive avoidance learning and memory and CaMKII-α gene expression impairments in hippocampus of rat. Pharmacol Rep. 2015 Apr;67(2):370-5. doi: 10.1016/j.pharep.2014.10.014. http://www.ncbi.nlm.nih.gov/pubmed/25712666 Deterioro cognitivo No 2015-04-01 00:00:00 2615 Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J. 2015 Jul;29(7):2681-9. doi: 10.1096/fj.14-264218. Epub 2015 Ma Español Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J. 2015 Jul;29(7):2681-9. doi: 10.1096/fj.14-264218. Epub 2015 Mar 24. http://www.ncbi.nlm.nih.gov/pubmed/25805829 Deterioro cognitivo No 2015-03-24 00:00:00 2574 Chang PK, Khatchadourian A, McKinney RA, Maysinger D. Docosahexaenoic acid (DHA): a modulator of microglia activity and dendritic spine morphology. J Neuroinflammation. 2015 Dec;12(1):244. doi: 10.1186/s12974-015-0244-5. Español Chang PK, Khatchadourian A, McKinney RA, Maysinger D. Docosahexaenoic acid (DHA): a modulator of microglia activity and dendritic spine morphology. J Neuroinflammation. 2015 Dec;12(1):244. doi: 10.1186/s12974-015-0244-5. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344754/ Deterioro cognitivo Full text 2015-01-01 00:00:00 2612 Street SJ, Parletta N, Milte C, Sullivan K, Hills AP, Buckley J, Howe P. Interaction of erythrocyte eicosapentaenoic acid and physical activity predicts reduced risk of mild cognitive impairment. Aging Ment Health. 2015 Oct;19(10):885-91. doi: 10.1080/136 Español Street SJ, Parletta N, Milte C, Sullivan K, Hills AP, Buckley J, Howe P. Interaction of erythrocyte eicosapentaenoic acid and physical activity predicts reduced risk of mild cognitive impairment. Aging Ment Health. 2015 Oct;19(10):885-91. doi: 10.1080/13607863.2014.971705. Epub 2014 Nov 6. http://www.ncbi.nlm.nih.gov/pubmed/25374153 Deterioro cognitivo No 2014-11-06 00:00:00 2578 Abdel-Wahab BA, Al-Qahtani JM, El-Safty SA. Omega-3 polyunsaturated fatty acids in large doses attenuate seizures, cognitive impairment, and hippocampal oxidative DNA damage in young kindled rats. Neurosci Lett. 2014 Oct 11. pii: S0304-3940(14)00806-4. Español Abdel-Wahab BA, Al-Qahtani JM, El-Safty SA. Omega-3 polyunsaturated fatty acids in large doses attenuate seizures, cognitive impairment, and hippocampal oxidative DNA damage in young kindled rats. Neurosci Lett. 2014 Oct 11. pii: S0304-3940(14)00806-4. http://www.ncbi.nlm.nih.gov/pubmed/25316163 Deterioro cognitivo No 2014-10-11 00:00:00 2581 Grayson DS, Kroenke CD, Neuringer M, Fair DA. Dietary Omega-3 Fatty Acids Modulate Large-Scale Systems Organization in the Rhesus Macaque Brain. J Neurosci. 2014 Feb 5;34(6):2065-74. doi: 10.1523/JNEUROSCI.3038-13.2014. Español Grayson DS, Kroenke CD, Neuringer M, Fair DA. Dietary Omega-3 Fatty Acids Modulate Large-Scale Systems Organization in the Rhesus Macaque Brain. J Neurosci. 2014 Feb 5;34(6):2065-74. doi: 10.1523/JNEUROSCI.3038-13.2014. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913863/ Deterioro cognitivo Full text 2014-02-04 00:00:00 2593 Wiesmann M, Kiliaan AJ, Claassen JA. Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab. 2013 Nov;33(11):1696-706. Español Wiesmann M, Kiliaan AJ, Claassen JA. Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab. 2013 Nov;33(11):1696-706. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824191/ Deterioro cognitivo Full text 2013-11-01 00:00:00 2631 O’Callaghan N, Parletta N, Milte CM et al. Telomere shortening in elderly people with mild cognitive impairment may be attenuated with omega-3 fatty acid supplementation: A randomised controlled pilot study. Nutrition. Available online 3 October 2013.In P Español O’Callaghan N, Parletta N, Milte CM et al. Telomere shortening in elderly people with mild cognitive impairment may be attenuated with omega-3 fatty acid supplementation: A randomised controlled pilot study. Nutrition. Available online 3 October 2013.In Press, Accepted Manuscript. http://www.ncbi.nlm.nih.gov/pubmed/24342530 Deterioro cognitivo No 2013-10-03 00:00:00 2600 O’Callaghan N, Parletta N, Milte CM et al. Telomere shortening in elderly people with mild cognitive impairment may be attenuated with omega-3 fatty acid supplementation: A randomised controlled pilot study. Nutrition. Available online 3 October 2013.In P Español O’Callaghan N, Parletta N, Milte CM et al. Telomere shortening in elderly people with mild cognitive impairment may be attenuated with omega-3 fatty acid supplementation: A randomised controlled pilot study. Nutrition. Available online 3 October 2013.In Press, Accepted Manuscript. http://www.sciencedirect.com/science/article/pii/S0899900713004450 Deterioro cognitivo No 2013-10-01 00:00:00 2622 Witte AV, Kerti L, Hermannstädter HM et al. Long-Chain Omega-3 Fatty Acids Improve Brain Function and Structure in Older Adults. Cereb Cortex. 2013 Jun 24. Español Witte AV, Kerti L, Hermannstädter HM et al. Long-Chain Omega-3 Fatty Acids Improve Brain Function and Structure in Older Adults. Cereb Cortex. 2013 Jun 24. http://www.ncbi.nlm.nih.gov/pubmed/23796946 Deterioro cognitivo No 2013-06-24 00:00:00 2604 Denis I, Potier B, Vancassel S, Heberden C, Lavialle M. Omega-3 fatty acids and brain resistance to ageing and stress: body of evidence and possible mechanisms. Ageing Res Rev. 2013 Mar;12(2):579-94. Español Denis I, Potier B, Vancassel S, Heberden C, Lavialle M. Omega-3 fatty acids and brain resistance to ageing and stress: body of evidence and possible mechanisms. Ageing Res Rev. 2013 Mar;12(2):579-94. http://www.ncbi.nlm.nih.gov/pubmed/23395782 Deterioro cognitivo No 2013-03-12 00:00:00 2590 Avramovic N, Dragutinovic V, Krstic D et al. The effects of omega 3 fatty acid supplementation on brain tissue oxidative status in aged wistar rats. Hippokratia. 2012 Jul;16(3):241-5. Español Avramovic N, Dragutinovic V, Krstic D et al. The effects of omega 3 fatty acid supplementation on brain tissue oxidative status in aged wistar rats. Hippokratia. 2012 Jul;16(3):241-5. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738731/ Deterioro cognitivo Full text 2012-07-16 00:00:00 2584 Samieri C, Maillard P, Crivello F, Proust-Lima C, Peuchant E, Helmer C, Amieva H, Allard M, Dartigues JF, Cunnane SC, Mazoyer BM, Barberger-Gateau P. Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe. Neurology. 2012; 79:642-65 Español Samieri C, Maillard P, Crivello F, Proust-Lima C, Peuchant E, Helmer C, Amieva H, Allard M, Dartigues JF, Cunnane SC, Mazoyer BM, Barberger-Gateau P. Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe. Neurology. 2012; 79:642-650. http://www.neurology.org/content/79/7/642 Deterioro cognitivo No 2012-01-01 00:00:00 2628 Nilsson A, Radeborg K, Salo I et al. Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study. Nutr J 2012;11 Español Nilsson A, Radeborg K, Salo I et al. Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study. Nutr J 2012;11:99. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564898/pdf/1475-2891-11-99.pdf Deterioro cognitivo Full text 2012-01-01 00:00:00 2599 Bowman GL, Silbert LC, Howieson D, Dodge HH, Traber MG, Frei B, Kaye JA, Shannon J, Quinn JF. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology. 2012; 78:241-249. Español Bowman GL, Silbert LC, Howieson D, Dodge HH, Traber MG, Frei B, Kaye JA, Shannon J, Quinn JF. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology. 2012; 78:241-249. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280054/ Deterioro cognitivo Full text 2012-01-01 00:00:00 2589 Tan ZS, Harris WS, Beiser AS et al. Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology. 2012; 78:658-664. Español Tan ZS, Harris WS, Beiser AS et al. Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology. 2012; 78:658-664. http://www.neurology.org/content/78/9/658 Deterioro cognitivo No 2012-01-01 00:00:00 2603 Matesanz N, Park G, McAllister H et al. Docosahexaenoic acid improves the nitroso-redox balance and reduces VEGF-mediated angiogenic signaling in microvascular endothelial cells. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6815-25. Español Matesanz N, Park G, McAllister H et al. Docosahexaenoic acid improves the nitroso-redox balance and reduces VEGF-mediated angiogenic signaling in microvascular endothelial cells. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6815-25. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055780/ Deterioro cognitivo No 2010-12-01 00:00:00 2596 Yurko-Mauro K, McCarthy D, Rom D et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010 Nov;6(6):456-64. doi: 10.1016/j.jalz.2010.01.013. Español Yurko-Mauro K, McCarthy D, Rom D et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010 Nov;6(6):456-64. doi: 10.1016/j.jalz.2010.01.013. http://www.ncbi.nlm.nih.gov/pubmed/?term=Yurko-Mauro%20K%2C%20McCarthy%20D%2C%20Rom%20D%202010 Deterioro cognitivo No 2010-11-06 00:00:00 2607 Zhang F, Yang H, Pan Z et al. Dependence of resolvin-induced increases in corneal epithelial cell migration on EGF receptor transactivation. Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5601-9. Español Zhang F, Yang H, Pan Z et al. Dependence of resolvin-induced increases in corneal epithelial cell migration on EGF receptor transactivation. Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5601-9. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061499/ Deterioro cognitivo Full text 2010-11-01 00:00:00 2608 Yurko-Mauro K, McCarthy D, Rom D et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010 Nov;6(6):456-64. doi: 10.1016/j.jalz.2010.01.013. Español Yurko-Mauro K, McCarthy D, Rom D et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010 Nov;6(6):456-64. doi: 10.1016/j.jalz.2010.01.013. http://www.ncbi.nlm.nih.gov/pubmed/?term=Yurko-Mauro%20K%2C%20McCarthy%20D%2C%20Rom%20D%202010 Deterioro cognitivo No 2010-01-13 00:00:00 2635 Marszalek JR, Lodish HF. Docosahexaenoic acid, fatty acid-interacting proteins and neural function. Annual Review of Cell and Development Biology 2005; 21: 633-657. Español Marszalek JR, Lodish HF. Docosahexaenoic acid, fatty acid-interacting proteins and neural function. Annual Review of Cell and Development Biology 2005; 21: 633-657. http://www.ncbi.nlm.nih.gov/pubmed/16212510 Deterioro cognitivo No 2005-01-01 00:00:00 2619 Cenacchi T, Bertoldin T, Farina C, Fiori MG, Crepaldi G. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging Clin Exp Res 1993; 5: 123-33. Español Cenacchi T, Bertoldin T, Farina C, Fiori MG, Crepaldi G. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging Clin Exp Res 1993; 5: 123-33. http://www.ncbi.nlm.nih.gov/pubmed/8323999 Deterioro cognitivo No 1993-01-01 00:00:00 2611

Epilepsia

Ibrahim FAS, Ghebremeskel K, Abdel-Rahman ME, Ahmed AAM, Mohmed IM, Osman G, et al. The differential effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on seizure frequency in patients with drug-resistant epilepsy - A randomized, double Español Ibrahim FAS, Ghebremeskel K, Abdel-Rahman ME, Ahmed AAM, Mohmed IM, Osman G, et al. The differential effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on seizure frequency in patients with drug-resistant epilepsy - A randomized, double-blind, placebo-controlled trial. Epilepsy Behav. 2018;87:32-8. https://www.ncbi.nlm.nih.gov/pubmed/30170260 Epilepsia No 2018-10-21 00:00:00 5074 Tejada S, Martorell M, Capó X et al. Omega-3 Fatty Acids in the Management of Epilepsy. Curr Top Med Chem. 2016 Feb 4. [Epub ahead of print] Español Tejada S, Martorell M, Capó X et al. Omega-3 Fatty Acids in the Management of Epilepsy. Curr Top Med Chem. 2016 Feb 4. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26845549 Epilepsia No 2016-02-04 00:00:00 3410 Scorza FA. Sudden unexpected death in children with epilepsy: Focus on dietary supplementation with omega-3 polyunsaturated fatty acids. Epilepsy Behav. 2015 Feb 25;44C:169-170. doi: 10.1016/j.yebeh.2015.01.002. Español Scorza FA. Sudden unexpected death in children with epilepsy: Focus on dietary supplementation with omega-3 polyunsaturated fatty acids. Epilepsy Behav. 2015 Feb 25;44C:169-170. doi: 10.1016/j.yebeh.2015.01.002. http://www.ncbi.nlm.nih.gov/pubmed/25725327 Epilepsia No 2015-02-25 00:00:00 3021 Taha AY, Ciobanu FA, Saxena A, McIntyre Burnham W. Assessing the link between omega-3 fatty acids, cardiac arrest, and sudden unexpected death in epilepsy. Epilepsy Behav. 2009 Jan;14(1):27-31. Epub 2008 Dec 2. Español Taha AY, Ciobanu FA, Saxena A, McIntyre Burnham W. Assessing the link between omega-3 fatty acids, cardiac arrest, and sudden unexpected death in epilepsy. Epilepsy Behav. 2009 Jan;14(1):27-31. Epub 2008 Dec 2. http://www.ncbi.nlm.nih.gov/pubmed/18992844 Epilepsia No 2008-12-02 00:00:00 3022 Scorza FA, Cysneiros RM, Arida RM, Terra-Bustamante VC, de Albuquerque M, Cavalheiro EA. The other side of the coin: Beneficiary effect of omega-3 fatty acids in sudden unexpected death in epilepsy. Epilepsy Behav. 2008 Aug;13(2):279-83. Español Scorza FA, Cysneiros RM, Arida RM, Terra-Bustamante VC, de Albuquerque M, Cavalheiro EA. The other side of the coin: Beneficiary effect of omega-3 fatty acids in sudden unexpected death in epilepsy. Epilepsy Behav. 2008 Aug;13(2):279-83. http://www.ncbi.nlm.nih.gov/pubmed/18511348 Epilepsia No 2008-08-01 00:00:00 3018

Esclerosis lateral amiotrófica

Cacabelos D, Ayala V, Granado-Serrano AB et al. Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis. Neurobiol Dis. 2016 Jan 12;88:148-160. doi: 10.1016/j.nbd.2016.01.007. [Epub ahead of print] Español Cacabelos D, Ayala V, Granado-Serrano AB et al. Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis. Neurobiol Dis. 2016 Jan 12;88:148-160. doi: 10.1016/j.nbd.2016.01.007. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26805387 Esclerosis lateral amiotrófica No 2016-01-12 00:00:00 3430

Fibrosis quística

Eickmeier O, Fussbroich D, Mueller K, Serve F, Smaczny C, Zielen S, et al. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis. PLoS One. 2017;12(2):e0171249. Español Eickmeier O, Fussbroich D, Mueller K, Serve F, Smaczny C, Zielen S, et al. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis. PLoS One. 2017;12(2):e0171249. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291435/pdf/pone.0171249.pdf Fibrosis quística Full text 2017-07-12 00:00:00 4257 Hanssens L, Thiébaut I, Lefèvre N et al. The clinical benefits of long-term supplementation with omega-3 fatty acids in cystic fibrosis patients - A pilot study. Prostaglandins Leukot Essent Fatty Acids. 2016 May;108:45-50. doi: 10.1016/j.plefa.2016.03.01 Español Hanssens L, Thiébaut I, Lefèvre N et al. The clinical benefits of long-term supplementation with omega-3 fatty acids in cystic fibrosis patients - A pilot study. Prostaglandins Leukot Essent Fatty Acids. 2016 May;108:45-50. doi: 10.1016/j.plefa.2016.03.014. Epub 2016 Mar 28. http://www.ncbi.nlm.nih.gov/pubmed/27154364 Fibrosis quística No 2016-03-28 00:00:00 3414 Oliver C, Watson H. Omega-3 fatty acids for cystic fibrosis. Cochrane Database Syst Rev. 2016 Jan 5;1:CD002201. [Epub ahead of print] Español Oliver C, Watson H. Omega-3 fatty acids for cystic fibrosis. Cochrane Database Syst Rev. 2016 Jan 5;1:CD002201. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26730723 Fibrosis quística No 2016-01-05 00:00:00 3415

Memoria

Külzow N, Witte AV, Kerti L et al. Impact of Omega-3 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults. J Alzheimers Dis. 2016 Feb 10. [Epub ahead of print] Español Külzow N, Witte AV, Kerti L et al. Impact of Omega-3 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults. J Alzheimers Dis. 2016 Feb 10. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26890759 Memoria No 2016-02-10 00:00:00 3492 Boespflug EL, McNamara RK, Eliassen JC et al. Fish Oil Supplementation Increases Event-Related Posterior Cingulate Activation in Older Adults with Subjective Memory Impairment. J Nutr Health Aging. 2016;20(2):161-9. doi: 10.1007/s12603-015-0609-6. Español Boespflug EL, McNamara RK, Eliassen JC et al. Fish Oil Supplementation Increases Event-Related Posterior Cingulate Activation in Older Adults with Subjective Memory Impairment. J Nutr Health Aging. 2016;20(2):161-9. doi: 10.1007/s12603-015-0609-6. http://www.ncbi.nlm.nih.gov/pubmed/26812512 Memoria No 2016-02-01 00:00:00 3489 Gharami K, Das M, Das S. Essential role of docosahexaenoic acid towards development of a smarter brain. Neurochem Int. 2015 Oct;89:51-62. Español Gharami K, Das M, Das S. Essential role of docosahexaenoic acid towards development of a smarter brain. Neurochem Int. 2015 Oct;89:51-62. http://www.ncbi.nlm.nih.gov/pubmed/26321578 Memoria No 2015-10-01 00:00:00 3101 Nilsson A, Radeborg K, Salo I et al. Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study. Nutr J 2012;11 Español Nilsson A, Radeborg K, Salo I et al. Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study. Nutr J 2012;11:99. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564898/pdf/1475-2891-11-99.pdf Memoria Full text 2012-01-01 00:00:00 2567 Vakhapova V, Cohen T, Richter Y, Herzog Y, Korczyn AD. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dement Geriatr Cogn Disord. 2010 Español Vakhapova V, Cohen T, Richter Y, Herzog Y, Korczyn AD. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dement Geriatr Cogn Disord. 2010;29(5):467-74. http://www.ncbi.nlm.nih.gov/pubmed/20523044 Memoria No 2010-01-01 00:00:00 2570 Frais AT. Depression and the causal role of specific memory system degenerations: link may be supported by reported therapeutic benefits of Omega 3 fatty acids. Med Hypotheses. 2007;69(1):67-9. Español Frais AT. Depression and the causal role of specific memory system degenerations: link may be supported by reported therapeutic benefits of Omega 3 fatty acids. Med Hypotheses. 2007;69(1):67-9. http://www.ncbi.nlm.nih.gov/pubmed/17368750 Memoria No 2007-01-01 00:00:00 2562